Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency - PubMed

Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency

T Sengupta et al. Neurochem Res. 2011 Jan.

Abstract

Hyoscyamus species is one of the four plants used in Ayurveda for the treatment of Parkinson's disease (PD). Since Hyoscyamus niger was found to contain negligible levels of L-DOPA, we evaluated neuroprotective potential, if any, of characterized petroleum ether and aqueous methanol extracts of its seeds in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD in mice. Air dried authenticated H. niger seeds were sequentially extracted using petroleum ether and aqueous methanol and were characterized employing HPLC-electrochemistry and LCMS. Parkinsonian mice were treated daily twice with the extracts (125-500 mg/kg, p.o.) for two days and motor functions and striatal dopamine levels were assayed. Administration of the aqueous methanol extract (containing 0.03% w/w of L-DOPA), but not petroleum ether extract, significantly attenuated motor disabilities (akinesia, catalepsy and reduced swim score) and striatal dopamine loss in MPTP treated mice. Since the extract caused significant inhibition of monoamine oxidase activity and attenuated 1-methyl-4-phenyl pyridinium (MPP+)-induced hydroxyl radical (·OH) generation in isolated mitochondria, it is possible that the methanolic extract of Hyoscyamus niger seeds protects against parkinsonism in mice by means of its ability to inhibit increased ·OH generated in the mitochondria.

Similar articles

• [Parkinsonism induced by MPTP and free radical generation].

  Obata T, Yamanaka Y. Obata T, et al. Nihon Yakurigaku Zasshi. 2001 Feb;117(2):105-10. doi: 10.1254/fpj.117.105. Nihon Yakurigaku Zasshi. 2001. PMID: 11233301 Review. Japanese.

• D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.

  Muralikrishnan D, Samantaray S, Mohanakumar KP. Muralikrishnan D, et al. Synapse. 2003 Oct;50(1):7-13. doi: 10.1002/syn.10239. Synapse. 2003. PMID: 12872288

• Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.

  Mohanakumar KP, Muralikrishnan D, Thomas B. Mohanakumar KP, et al. Brain Res. 2000 May 12;864(2):281-90. doi: 10.1016/s0006-8993(00)02189-2. Brain Res. 2000. PMID: 10802035

• Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset.

  Hamadjida A, Nuara SG, Kwan C, Frouni I, Bédard D, Gourdon JC, Huot P. Hamadjida A, et al. Naunyn Schmiedebergs Arch Pharmacol. 2020 Nov;393(11):2157-2164. doi: 10.1007/s00210-020-01933-y. Epub 2020 Jul 3. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 32621059

• The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.

  Jenner P, Marsden CD. Jenner P, et al. J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review.

Cited by

• Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.

  Koppula S, Kumar H, More SV, Lim HW, Hong SM, Choi DK. Koppula S, et al. Molecules. 2012 Sep 26;17(10):11391-420. doi: 10.3390/molecules171011391. Molecules. 2012. PMID: 23014498 Free PMC article. Review.

• An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry.

  Khan AW, Khan AU, Shah SMM, Ullah A, Faheem M, Saleem M. Khan AW, et al. Evid Based Complement Alternat Med. 2019 Mar 3;2019:6191505. doi: 10.1155/2019/6191505. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 30941198 Free PMC article. Review.

• A review: traditional herbs and remedies impacting pathogenesis of Parkinson's disease.

  Sharma V, Bedi O, Gupta M, Deshmukh R. Sharma V, et al. Naunyn Schmiedebergs Arch Pharmacol. 2022 May;395(5):495-513. doi: 10.1007/s00210-022-02223-5. Epub 2022 Mar 8. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35258640 Review.

• The regulation of NFKB1 on CD200R1 expression and their potential roles in Parkinson's disease.

  Lin S, Shu Y, Shen R, Zhou Y, Pan H, He L, Fang F, Zhu X, Wang X, Wang Y, Xu W, Ding J. Lin S, et al. J Neuroinflammation. 2024 Sep 18;21(1):229. doi: 10.1186/s12974-024-03231-3. J Neuroinflammation. 2024. PMID: 39294682 Free PMC article.

• Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases: Expanding the Therapeutic Approaches by Plant-Derived Natural Products.

  Zhang X, Wang L, Li B, Shi J, Xu J, Yuan M. Zhang X, et al. Pharmaceuticals (Basel). 2023 Feb 13;16(2):277. doi: 10.3390/ph16020277. Pharmaceuticals (Basel). 2023. PMID: 37259422 Free PMC article. Review.

References

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information